The economic burden of depression in the US: Societal and patient perspectives

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 3, 2005, Pages 369-376

  Greenberg, Paul E ^a   Birnbaum, Howard G ^a  

^a ANALYSIS GROUP   (United States)

Author keywords

Cost of illness; Depression; Direct costs; Indirect costs

Indexed keywords

ANTIDEPRESSANT AGENT;

ABSENTEEISM; CAREGIVER; COMORBIDITY; CONSULTATION; DAILY LIFE ACTIVITY; DATA ANALYSIS; DEPRESSION; ECONOMIC ASPECT; EMPLOYER; FAMILY LIFE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH INSURANCE; HUMAN; JOB PERFORMANCE; MEDICAL LITERATURE; MENTAL HEALTH SERVICE; OUTCOMES RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PRODUCTIVITY; PROSPECTIVE PAYMENT; REIMBURSEMENT; REVIEW; SOCIAL ASPECT; UNITED STATES;

COST OF ILLNESS; DEPRESSION; HEALTH CARE COSTS; HUMANS; UNITED STATES;

EID: 17144398877     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.3.369     Document Type: Review

References (62)

1. MALZBERG B: Mental Illness and the Economic Value of Man. In: Mental Hygiene (1950) 34:225-227.
2. FEIN R: Economics and Mental Illness: A Report to the Staff Director. Jack R. Ewalt (Ed.), Basic Books, New York, NY, USA (1958).
3. JARVINEN D: Cost of Illness Studies: An Annotated Bibliography. Institute for Health & Aging, University of California, San Francisco, CA, USA (1988).
4. ROSENBAUM JF, HYLAN TR. Costs of Depressive Disorders: a review. In: Depressive Disorders. Maj M, Sartorius N (Eds.), WPA Series, Evidence and Experience in Psychiatry (1999):401-449.
5. GREENBERG PE, STIGLIN LE, FINKELSTEIN SN et al.: Depression: A Neglected Major Illness. J. Clin. Psychiatry (1993) 54(11):419-424.
6. WELLS KB, STEWART A, HAYS RD et al.: The functioning and well-being of depressed patients: results from the medical outcomes study. J. Am. Med. Assoc. (1989) 262:914-919.
7. WORLD HEALTH ORGANIZATION: The World Health Report 2001: Mental Health: New Understanding, New Hope. Geneva, Switzerland (2001).
8. KATON W, VON KORFF M, LIN E et al.: Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen. Hosp. Psych. (1990) 12:355-362.
9. VON KORFF M, ORMEL J, KATON W et al.: Disability and depression among high utilizers of health care: a longitudinal analysis. Arch. Gen. Psychiatry (1992) 49(2):91-100.
10. GREENBERG PE, BIRNBAUM HG: The workplace burden of depression: underlying causes, recent empirical findings, and future directions. TEN (2000) 2(6):37-40.
11. KESSLER RC, FOSTER CL, SAUNDERS WB et al.: Social consequences of psychiatric disorders, I: educational attainment. Am. J. Psychiatry (1995) 152(7):1026-1032.
12. KESSLER RC, BERGLUND PA, FOSTER CL et al.: Social consequences of psychiatric disorders, II: teenage parenthood. Am. J. Psychiatry (1997) 154:1405-1411.
13. KESSLER RC, WALTERS EE, FORTHOFER MS: The social consequences of psychiatric disorders, III: probability of marital stability. Am. J. Psychiatry (1998) 155:1092-1096.
14. ROST K, SMITH GR, MATTHEWS DB et al.: The deliberate misdiagnosis of major depression in primary care. Arch. Fam. Med. (1994) 3(4):333-337.
15. RUBENSTEIN LV, JACKSON-TRICHE M, UNÜTZER J et al.: Evidence-based care for depression in managed primary care practices. Health Aff. (1999) 18(5):89-105.
16. KESSLER RC, BERGLUND P DEMLER O et al.: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. (2003) 289(23):3095-3105.
17. CHARBONNEAU A, ROSEN AK, ASH AS et al.: Measuring the quality of depression care in a large integrated health system. Med. Care (2003) 41:669-680.
18. BRUCE ML, WELLS KB, MIRANDA J et al.: Barriers to reducing burden of affective disorder. Ment. Health Serv. Res. (2002) 4:187-197.
19. AMERICAN PSYCHIATRIC ASSOCIATION: Practice Guidelines for the Treatment of Patients with Major Depression, 2nd edn. American Psychiatric Association Press, Washington, DC, USA (2000).
20. AGENCY FOR HEALTH CARE POLICY AND RESEARCH: Depression in Primary Care (Volume 2): Treatment of Major Depression. US Dept of Health and Human Services, Rockville, Maryland, USA (1993).
21. STOUDEMIRE A, FRANK R, HEDEMARK N et al.: The economic burden of depression. Gen. Hosp. Psychiatry (1986) 8:387-394.
22. GREENBERG PE, STIGLIN LE, FINKELSTEIN SN et al.: The economic burden of depression in 1990. J. Clin. Psychiatry (1993) 54(11):405-418.
23. SARTORIUS N: The economic and social burden of depression. J. Clin. Psychiatry (2001) 62(Supp). 15):8-11.
24. FOSTER T, GILLESPIE K, MCCLELLAND R et al.: Risk factors for suicide independent of DSM-III-R Axis I disorder. Br. J. Psychiatry (1999) 175:175-179.
25. HENRIKSSON MM, ARO HM, MARTTUNEN MJ et al.: Mental disorders and comorbidity in suicide. Am. J. Psychiatry (1993) 150(6):935-940.
26. RICH CL, YOUNG D, FOWLER RC: San Diego suicide study, I: young versus old subjects. Arch. Gen. Psychiatry (1986) 43 577-582.
27. BARRACLOUGH B, BUNCH J, NELSON B et al.: A hundred cases of suicide: clinical aspects. Br. J. Psychiatry (1974) 125 355-373.
28. LEVIT K, SMITH C, COWAN C et al.: Health Spending Rebound Continues in 2002. Health Aff. (2004) 23(1):147-159.
29. RICE DP, MILLER LS: The economic burden of affective disorders. Br. J. Psychiatry Suppl. (1995):34-42.
30. BRUGHA TS, JENKINS R, TAUB N et al.: A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol. Med. (2001) 31(6):1001-1013.
31. EVANS M, KESSLER D, LEWIS G et al.: Assessing mental health in primary care research using standardized scales: can it be carried out over the telephone? Psychol. Med. (2004) 34 1):157-162.
32. GREENBERG PE, KESSLER RC, NELLS TL et al.: Depression in the workplace: an economic perspective. Selective Serotonin Re-uptake Inhibitors: Advances in Basic Research and Clinical Practice, Second Edition. Feighner JP, Boyer WF (Eds.), John Wiley & Sons Ltd., New York, NY, USA (1996):327-363.
33. KESSLER RC, MCGONAGLE KA, ZHAO S et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry (1994) 51(1):8-19.
34. GREENBERG PE, KESSLER RC, BIRNBAUM HG et al.: The Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000? J. Clin. Psychiatry (2003) 64 12):1465-1474.
35. OLFSON M, MARCUS SC, DRUSS B et al.: National trends in the outpatient treatment of depression. J. Am. Med. Assoc. (2002) 287(2):203-209.
36. GOFF VV: Depression: a decade of progress, more to do. NHPF Issue Brief (2002):1-14.
37. ZUVEKAS S: Trends in mental health services use and spending, 1987-1996. Health Aff. (2001) 20(2):214-224.
38. STURM R, WELLS KB: How can care for depression become more cost-effective? JAMA (1995) 74(1):51-58.
39. WELLS KB, STURM R: Care for depression in a changing environment. Health Aff. (1995) 14(3):78-89.
40. FRANK RG, MCGUIRE TG, NORMAND S-L et al.: The value of mental health care at the system level: The case of treating depression. Health Aff. (1999) 18(5):71-88.
41. VALENSTEIN M, VIJAN S, ZEBER JE et al.: The cost utility of screening for depression in primary care. Ann. Intern. Med. (2001) 134(5):345-360.
42. FRANK RG, HUSKAMP HA, PINCUS HA: Aligning incentives in the treatment of depression in primary care with evidence-based practice. Psychiatr. Serv. (2003) 54(5):682-687.
43. O'BRIEN E: Employers' benefit from workers' health insurance. Millbank Quarterly (2003) 81(1):5-43.
44. STEWART WF, RICCI JA, CHEE E et al.: Cost of lost productive work time among US workers with depression. JAMA (2003) 289(3):3135-3144.
45. BIRNBAUM HG, GREENBERG PE, KESSLER RC et al.: Workplace Burden of Depression: a case study in social function using employer claims data. Drug Benefit Trends (1999) 11(8):6-12.
46. COREY-LISLE PK, BIRNBAUM HG, GREENBERG PE et al.: Identification of a claims data 'signature' and economic consequences for treatment-resistant depression. J. Clin. Psychiatry (2002) 63 8):717-726.
47. GOETZEL RZ, HAWKINS K, OZMINKOWSKI RJ, WANG S: The health and productivity cost burden of the 'top 10' physical and mental health conditions affecting six large US employers in 1999. J. Occup. Environ. Medicine (2003) 45(1):5-14.
48. BRYANT-COMSTOCK L, STENDER M, DEVERCELLI G: Health care utilisation and costs among privately insured patients with bipolar I disorder. Bipolar Disorder (2002) 4(6):398-405.
49. BIRNBAUM HG, SHI L, DIAL E et al.: Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis. J. Clin. Psychiatry (2003) 64(10):1201-1209.
50. BIRNBAUM HG, GREENBERG PE, BARTON M et al.: Workplace burden of depression: a case study in social functioning using employer claims data. Drug Benefit Trends (1999) 11(8):6-12.
51. SHEEHAN DV: Establishing the real cost of depression. Managed Care (2002) 11(1):7-10.
52. GREENBERG PE, LEONG SA, BIRNBAUM HG, ROBINSON RL: The economic burden of depression with painful symptoms. J. Clin. Psychiatry (2003) 64(Suppl. 7):17-23.
53. GREENBERG PE, BIRNBAUM HG, MOYNEUR E et al.: The direct health care costs of depressive disorders in the US: a patient time profile. Poster presentation at European College of Neuropsychopharmacology (2003), Prague, Czech Republic.
54. SIMON GE, BARBER C, BIRNBAUM HG et al.: Depression and work productivity: the comparative costs of treatment versus non-treatment. J. Occup. Environ. Med. (2001) 43:2-9.
55. ANDREWS G, ISSAKIDIS C, SANDERSON K et al.: Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br. J. Psychiatry (2004) 184:526-533.
56. SMIT F, BEEKMAN A, CUIJPERS P et al.: Selecting key variables for depression prevention: results from a prospective population-based cohort study. J. Affect. Disord. (2004) 81 241-249.
57. BERTO P, D'ILARIO D, RUFFO P et al.: Depression: cost-of-illness studies in the international literature, a review. J. Ment. Health Policy Econ. (2000) 3(1):3-10.
58. LEPINE JP, GASTPAR M, MENDLEWICZ J et al.: Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int. Clin. Psychopharmacol. (1997) 12(1):19-29.
59. LÖTHGREN M: Economic evidence in affective disorders: a review. Eur. J. Health Econ. (2004) (Suppl. 1):S12-S19.
60. USTUN TB, AYUSO-MATEOS JL, CHATTERJI S et al.: Global burden of depressive disorders in the year 2000. Br. J. Psychiatry (2004) 184:386-392.
61. UNÜTZER J, PATRICK DL, SIMON G et al.: Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. J. Am. Med. Assoc. (1997) 277:1618-1623.
62. KATON WJ, LIN E, RUSSO J, UNÜTZER J: Increased medical costs of a population-based sample of depressed elderly patients. Arch. Gen. Psychiatry (2003) 60:897-903.